AUTL · Autolus Therapeutics plc · Executive Compensation
$1.14
-0.03 (-2.56%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Market Cap
$303.43M
Shares
266.16M
Volume · Nov 16
2.35M
Avg daily vol (3M)
2.13M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ryan Richardson | Class I director | Appointed | 2025-12-02 |
| Miranda Neville | Chief Technical Officer | Appointed | 2025-11-12 |
| Patrick McIlvenny | Principal Accounting Officer | Appointed | 2025-11-12 |
| Rob Dolski | principal accounting officer | Appointed | 2025-04-03 |
| Michael W. Bonney | Class II director | Appointed | 2024-04-01 |
| Ravi M. Rao | Class I director | Appointed | 2024-04-01 |
| Michael W. Bonney | Chair of the Board | Appointed | 2024-04-01 |
| John Johnson | Director | Resigned | 2024-04-01 |
| Robert (“Bob”) W. Azelby | Class II director | Appointed | 2024-01-10 |
| Elisabeth ("Lis") Leiderman, M.D. | Class II director | Appointed | 2023-12-22 |
| Kapil Dhingra, M.D. | member of the Board of Directors | Resigned | 2023-12-22 |
Leadership
- Michael W. Bonney Chairman, Board Member
- Patrick McIlvenny Chief Accounting Officer
- Rob Dolski Chief Accounting Officer
- Elisabeth ("Lis") Leiderman, M.D. Board Member
- Ravi M. Rao Board Member
- Robert (“Bob”) W. Azelby Board Member
- Ryan Richardson Board Member
Key facts
CIK
1730463
CUSIP
05280R100
13F (30d)
86 filings
71 filers
Visit website
Investor relations